CD8A and myeloid sarcoma: Some analysis of transcriptomic profiles of peripheral blood cells suggests that MS progression may also be triggered by Epstein-Barr Virus (EBV) reactivation, and increased CD8+ responses to lytic EBV antigens have been noted in blood samples from MS patient cohorts with higher ratios of female participants (Angelini et al., 2013).